A

Alvogen

573 employees

Alvogen is a manufacturer of pharmaceutical products.

Investor insights

Sectors invested in

Biotechnology2
Regenerative Medicine1
Regulatory1
Business Development1
Biogenerics1
Biosimilars1
Life Science1
Pharmaceutical1
Research and Development1
Biopharmaceuticals1
Health1
Cell Line Development1
Health Care1
Medical Device1
Medical1
Manufacturing1
Surgical1
Woundcare1
Fish-skin1
Dental1

Funding rounds participated in

$41M sweet spot round size

Most of their 2 investments are in rounds between $16M and $65M

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biosimilars
Generic pharmaceuticals
Branded pharmaceuticals
Health Care
Clinical Research
Contract manufacturing
Medical
Manufacturing
Pharmaceutical

Date founded

2009

Investments made

A

Alvotech raised $65M on October 27, 2020

Investors: Shinhan Capital Co., Ltd., Athos Capital and Alvogen

K

Kerecis raised $16M on June 13, 2019

Investors: Curae Lab, Novator Partners Llp, Emerson Collective and Alvogen

Funding rounds raised

A

Alvogen raised undisclosed on January 1, 2009

Investors: IMM Private Equity

FAQ